Elevated WHR showed a nonsignificant trend toward increased risk (aHR: 1.07, 95% CI: 0.99–1.14).
← all excerpts
Change in Metabolic Markers and the Risk of Skin Cancer: Results from the Lifelines Cohort Study in the Netherlands.
1
—
—
Elevated WHR showed a nonsignificant trend toward increased risk (aHR: 1.07, 95% CI: 0.99–1.14).